| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Inflammation Department, Wyeth Research, Cambridge, MA 02140; and
Institute of Biochemistry, Medical School Hannover, Hannover, Germany
TNF-
is a pleiotropic cytokine considered a primary mediator of immune regulation and inflammatory response and has been shown to play a central role in rheumatoid arthritis (RA). MAPKAP kinase 2 (MK2) is a serine/threonine kinase that is regulated through direct phosphorylation by p38 MAPK, and has been shown to be an essential component in the inflammatory response that regulates the biosynthesis of TNF- at a posttranscriptional level. The murine model of collagen-induced arthritis (CIA) is an established disease model to study pathogenic mechanisms relevant to RA. In this study, we report that deletion of the MK2 gene in DBA/1LacJ mice confers protection against CIA. Interestingly, the MK2 heterozygous mutants display an intermediate level of protection when compared with homozygous mutant and wild-type littermates. We show that MK2–/– and MK2+/– mice exhibit decreased disease incidence and severity in the CIA disease model and reduced TNF- and IL-6 serum levels following LPS/D-Gal treatment compared with wild-type mice. Additionally, we show that levels of IL-6 mRNA in paws of mice with CIA correlate with the disease status. These findings suggest that an MK2 inhibitor could be of great therapeutic value to treat inflammatory diseases like RA.
This article has been cited by other articles:
|
|
 |
|
  Y.-Y. Li, S. Ochs, Z.-R. Gao, A. Malo, C.-J. Chen, S. Lv, E. Gallmeier, B. Goke, and C. Schafer Regulation of HSP60 and the role of MK2 in a new model of severe experimental pancreatitis Am J Physiol Gastrointest Liver Physiol, November 1, 2009; 297(5): G981 - G989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bohm, S. Hayer, A. Kilian, M. M. Zaiss, S. Finger, A. Hess, K. Engelke, G. Kollias, G. Kronke, J. Zwerina, et al. The {alpha}-Isoform of p38 MAPK Specifically Regulates Arthritic Bone Loss J. Immunol., November 1, 2009; 183(9): 5938 - 5947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kuai, B. Gregory, A. Hill, D. D. Pittman, J. L. Feldman, T. Brown, B. Carito, M. O'Toole, R. Ramsey, O. Adolfsson, et al. TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines Rheumatology, November 1, 2009; 48(11): 1352 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Schett, J Zwerina, and G Firestein The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis Ann Rheum Dis, July 1, 2008; 67(7): 909 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Thalhamer, M. A. McGrath, and M. M. Harnett MAPKs and their relevance to arthritis and inflammation Rheumatology, April 1, 2008; 47(4): 409 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ruettger, S. Schueler, J. A. Mollenhauer, and B. Wiederanders Cathepsins B, K, and L Are Regulated by a Defined Collagen Type II Peptide via Activation of Classical Protein Kinase C and p38 MAP Kinase in Articular Chondrocytes J. Biol. Chem., January 11, 2008; 283(2): 1043 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jagavelu, U. J.F. Tietge, M. Gaestel, H. Drexler, B. Schieffer, and U. Bavendiek Systemic Deficiency of the MAP Kinase Activated Protein Kinase 2 Reduces Atherosclerosis in Hypercholesterolemic Mice Circ. Res., November 26, 2007; 101(11): 1104 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.F. Schindler, J.B. Monahan, and W.G. Smith p38 Pathway Kinases as Anti-inflammatory Drug Targets Journal of Dental Research, September 1, 2007; 86(9): 800 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. White, C. A. Pargellis, J. M. Studts, B. G. Werneburg, and B. T. Farmer II Molecular basis of MAPK-activated protein kinase 2:p38 assembly PNAS, April 10, 2007; 104(15): 6353 - 6358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ronkina, A. Kotlyarov, O. Dittrich-Breiholz, M. Kracht, E. Hitti, K. Milarski, R. Askew, S. Marusic, L.-L. Lin, M. Gaestel, et al. The Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPK Mol. Cell. Biol., January 1, 2007; 27(1): 170 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Olson, M. N. Hedrick, H. Izadi, T. C. Bates, E. R. Olivera, and J. Anguita p38 Mitogen-Activated Protein Kinase Controls NF-{kappa}B Transcriptional Activation and Tumor Necrosis Factor Alpha Production through RelA Phosphorylation Mediated by Mitogen- and Stress-Activated Protein Kinase 1 in Response to Borrelia burgdorferi Antigens Infect. Immun., January 1, 2007; 75(1): 270 - 277. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
